Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer

BACKGROUND: The consequences of low prostate-specific antigen (PSA) in high-grade (Gleason 8–10) prostate cancer are unknown. OBJECTIVE: To evaluate the clinical implications and genomic features of low-PSA, high-grade disease. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective study of cli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Mahal, Brandon A., Yang, David D., Wang, Natalie Q., Alshalalfa, Mohammed, Davicioni, Elai, Choeurng, Voleak, Schaeffer, Edward M., Ross, Ashley E., Spratt, Daniel E., Den, Robert B., Martin, Neil E., Mouw, Kent W., Orio, Peter F., Choueiri, Toni K., Taplin, Mary-Ellen, Trinh, Quoc-Dien, Feng, Felix Y., Nguyen, Paul L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6615042/
https://ncbi.nlm.nih.gov/pubmed/29478736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2018.01.043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados